Radioimmunotherapy of the non-Hodgkin's lymphomas

This publication has 62 references indexed in Scilit:

• Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
  Blood, 1994
• Retention of B-cell-specific monoclonal antibodies by human lymphoma cells
  Blood, 1994
• Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype
  Blood, 1989
• REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
  The Lancet, 1988
• Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas
  Blood, 1987
• Intracellular pathway of interleukin 2 following receptor‐mediated endocytosis
  European Journal of Immunology, 1986
• Expression of interleukin 2 receptor on Hodgkin's and non-Hodgkin's lymphomas and macrophages.
  Journal of Clinical Pathology, 1985
• Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
  Journal of Clinical Investigation, 1984
• Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
  New England Journal of Medicine, 1982
• Comparative density of the human T-cell antigen T65 on normal peripheral blood T cells and chronic lymphocytic leukemia cells
  Blood, 1981